Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Stefan Borgwardt; Renata Smieskova; Kerstin Bendfeldt; Eva Bühlmann; Gregor Berger; Jacqueline Aston; Ute Gschwandtner; Marlon Pflueger; Rolf Dieter Stieglitz; Anita Riecher-Rössler; Ernst Wilhelm Radue

Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?

Stefan Borgwardt^*, Renata Smieskova, Kerstin Bendfeldt, Eva Bühlmann, Gregor Berger, Jacqueline Aston, Ute Gschwandtner, Marlon Pflueger, Rolf Dieter Stieglitz, Anita Riecher-Rössler, Ernst Wilhelm Radue

^*Corresponding author for this work

Department of Psychiatry, Psychosomatics and Psychotherapie

4 Citations (Scopus)

Original language	English
Journal	Journal of Psychiatry and Neuroscience
Volume	35
Issue number	3
Pages (from-to)	214-215
Number of pages	2
ISSN	1180-4882
Publication status	Published - 05.2010

Funding

Competing interests: Dr. Borgwardt’s research was supported by a personal grant from the Swiss National Science Foundation (PBBSB-106936). The sponsor had no role in the intellectual work, writing of this letter, or the decision to submit this letter for publication. Dr. Berger has received speaker honoraria from AstraZeneca, Lilly, and Janssen-Cilag. None declared for all other authors.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being
SDG 10 Reduced Inequalities

Cite this

@article{d881ae0ba4b6469cb8d369c9aef97338,

title = "Hippocampal volume reduction specific for later transition to psychosis or substance-associated effects?",

author = "Stefan Borgwardt and Renata Smieskova and Kerstin Bendfeldt and Eva B{\"u}hlmann and Gregor Berger and Jacqueline Aston and Ute Gschwandtner and Marlon Pflueger and Stieglitz, \{Rolf Dieter\} and Anita Riecher-R{\"o}ssler and Radue, \{Ernst Wilhelm\}",

note = "Funding Information: Competing interests: Dr. Borgwardt{\textquoteright}s research was supported by a personal grant from the Swiss National Science Foundation (PBBSB-106936). The sponsor had no role in the intellectual work, writing of this letter, or the decision to submit this letter for publication. Dr. Berger has received speaker honoraria from AstraZeneca, Lilly, and Janssen-Cilag. None declared for all other authors. ",

year = "2010",

month = may,

language = "English",

volume = "35",

pages = "214--215",

journal = "Journal of Psychiatry and Neuroscience",

issn = "1180-4882",